Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122907554 | 12290755 | 4 | F | 201512 | 20160901 | 20160421 | 20160906 | PER | US-PFIZER INC-2016225828 | PFIZER | 67.00 | YR | F | Y | 80.00000 | KG | 20160906 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122907554 | 12290755 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | Oral | 50 MG, DAILY, CYCLIC (4 WEEKS ON AND 2 WEEKS OFF) | Y | 21938 | 50 | MG | CAPSULE, HARD | ||||||
| 122907554 | 12290755 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 50 MG, DAILY | Y | 21938 | 50 | MG | CAPSULE, HARD | ||||||
| 122907554 | 12290755 | 3 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 50 MG, CYCLIC, (DAILY, 4 WEEKS ON AND 2 WEEKS OFF, TO BE REPEATED EVERY 6 WEEKS) | Y | 21938 | 50 | MG | CAPSULE, HARD | ||||||
| 122907554 | 12290755 | 4 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 25 MG, DAILY | 0 | 25 | MG | |||||||||
| 122907554 | 12290755 | 5 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 25 MG, 2X/DAY | 0 | 25 | MG | BID | ||||||||
| 122907554 | 12290755 | 6 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | 25 MG, 2X/DAY | 0 | 25 | MG | BID | ||||||||
| 122907554 | 12290755 | 7 | C | LOTREL | AMLODIPINE BESYLATEBENAZEPRIL HYDROCHLORIDE | 1 | UNK, 1X/DAY (10/20 MG) | 0 | QD | ||||||||||
| 122907554 | 12290755 | 8 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 150 UG, DAILY | 0 | 150 | UG | |||||||||
| 122907554 | 12290755 | 9 | C | BISOPROLOL | BISOPROLOL | 1 | 10 MG, DAILY | 0 | 10 | MG | |||||||||
| 122907554 | 12290755 | 10 | C | BISOPROLOL | BISOPROLOL | 1 | 10 MG, 2X/DAY | 0 | 10 | MG | BID | ||||||||
| 122907554 | 12290755 | 11 | C | ASPIRIN. | ASPIRIN | 1 | 1 DF, DAILY | 0 | 1 | DF | |||||||||
| 122907554 | 12290755 | 12 | C | VITAMIN D | CHOLECALCIFEROL | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122907554 | 12290755 | 1 | Renal cell carcinoma stage IV |
| 122907554 | 12290755 | 4 | Hypertension |
| 122907554 | 12290755 | 7 | Hypertension |
| 122907554 | 12290755 | 9 | Hypertension |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122907554 | 12290755 | Abdominal pain | |
| 122907554 | 12290755 | Disease progression | |
| 122907554 | 12290755 | Fatigue | |
| 122907554 | 12290755 | Malaise | |
| 122907554 | 12290755 | Nausea | |
| 122907554 | 12290755 | Renal cell carcinoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122907554 | 12290755 | 1 | 201512 | 0 | ||
| 122907554 | 12290755 | 2 | 201512 | 0 | ||
| 122907554 | 12290755 | 3 | 20160831 | 0 | ||
| 122907554 | 12290755 | 4 | 1980 | 0 | ||
| 122907554 | 12290755 | 7 | 2000 | 0 | ||
| 122907554 | 12290755 | 10 | 2000 | 0 |